Abcellera Biologics Inc (ABCL)

May 01, 2026

AbCellera Biologics Among 3 Promising Penny Stocks - Yahoo Finance

May 01, 2026

Apr 30, 2026

Stifel Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $7 - Moomoo

Apr 30, 2026

Apr 29, 2026

AbCellera Biologics (NASDAQ:ABCL) Shares Down 7.6%Time to Sell? - MarketBeat

Apr 29, 2026

Apr 29, 2026

AbCellera (NASDAQ: ABCL) details 2026 vote on directors, auditor and Say-on-Pay - Stock Titan

Apr 29, 2026

Apr 29, 2026

Jones Trading initiates coverage of AbCellera Biologics (ABCL) with buy recommendation - MSN

Apr 29, 2026

Apr 27, 2026

Leerink Partners Downgrades AbCellera Biologics (ABCL) - MSN

Apr 27, 2026

Apr 24, 2026

AbCellera Biologics Pivots to In-House Pipeline, Teases Q3 Phase II Data for ABCL635 Hot Flashes - MarketBeat

Apr 24, 2026

Apr 24, 2026

AbCellera Biologics (NASDAQ:ABCL) Stock Price & News - The Motley Fool Canada

Apr 24, 2026

Apr 23, 2026

BMO Capital Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $7 - Moomoo

Apr 23, 2026

Apr 22, 2026

JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $11 - Moomoo

Apr 22, 2026

Apr 22, 2026

AbCellera (ABCL) Positioned Favorably Ahead of Phase 1 Update - GuruFocus

Apr 22, 2026

Apr 21, 2026

ABCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 21, 2026

Apr 21, 2026

AbCellera Biologics (ABCL) Is Up 6.8% After Announcing First Human Data Timeline For ABCL635 - simplywall.st

Apr 21, 2026

Apr 21, 2026

ABCL: Lead antibody for menopausal hot flashes nears pivotal phase II data, aiming for market differentiation - TradingView

Apr 21, 2026

Apr 21, 2026

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call - BioSpace

Apr 21, 2026

Apr 20, 2026

AbCellera to share Phase 1 data for menopause drug on May 11 - Investing.com Australia

Apr 20, 2026

Apr 20, 2026

JonesResearch Initiates Coverage of AbCellera Biologics Inc. (ABCL) - Insider Monkey

Apr 20, 2026

Apr 20, 2026

AbCellera to share Phase 1 data for menopause drug on May 11 By Investing.com - Investing.com South Africa

Apr 20, 2026

Apr 20, 2026

Press Release: AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call - Moomoo

Apr 20, 2026

Apr 20, 2026

10 Stocks Under $5 with Huge Upside Potential - Insider Monkey

Apr 20, 2026

Apr 17, 2026

AbCellera Biologics Inc. (ABCL): A bull case theory - MSN

Apr 17, 2026

Apr 17, 2026

AbCellera Biologics (ABCL) Committed to Leverage Differentiated Technology for Drug Discovery - MSN

Apr 17, 2026

Apr 17, 2026

AbCellera (ABCL): Among the stocks that could 10x over the next 5 years - MSN

Apr 17, 2026

Apr 17, 2026

AbCellera Biologics Inc. (ABCL) - DirectorsTalk Interviews

Apr 17, 2026

Apr 15, 2026

Truist reiterates Buy on AbCellera stock, eyes 2H26 data readout By Investing.com - Investing.com Canada

Apr 15, 2026

Apr 15, 2026

Truist reiterates Buy on AbCellera stock ahead of 2H26 data - Investing.com

Apr 15, 2026

Apr 15, 2026

Truist reiterates Buy on AbCellera stock ahead of 2H26 data By Investing.com - Investing.com Canada

Apr 15, 2026

Apr 15, 2026

Truist reiterates Buy on AbCellera stock, eyes 2H26 data readout - Investing.com

Apr 15, 2026

Apr 15, 2026

Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating - 富途牛牛

Apr 15, 2026

Apr 14, 2026

Biotech Penny Stocks Rally OABI ABCL PACB 2026 - Gotrade

Apr 14, 2026

Apr 14, 2026

Is Jones Trading’s New Coverage of AbCellera (ABCL) Reframing Its Clinical-Stage Platform Narrative? - Yahoo Finance

Apr 14, 2026

Apr 13, 2026

Is AbCellera Biologics Inc affected by consumer sentimentWall Street Watch & Free High Return Stock Watch Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Wall Street Bullish on AbCellera Biologics Inc. (ABCL), Here’s Why - MSN

Apr 13, 2026

Apr 13, 2026

Portfolio Recap: Is AbCellera Biologics Inc part of any ETFMarket Activity Summary & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Insider Sell: What hedge funds are buying AbCellera Biologics Inc2026 Fundamental Recap & Fast Entry High Yield Stock Tips - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

AbCellera Biologics Inc (HAM:8QQ) Stock Price & 30 Year Financial Data - GuruFocus

Apr 11, 2026

Apr 10, 2026

AbCellera Biologics Initiated at Buy by Jones Trading - Moomoo

Apr 10, 2026

Apr 10, 2026

AbCellera Biologics (ABCL): New 'Buy' Rating from Jones Trading - GuruFocus

Apr 10, 2026

Apr 10, 2026

JonesTrading Begins Coverage on AbCellera Biologics (NASDAQ:ABCL) - MarketBeat

Apr 10, 2026

Apr 10, 2026

Tudor Investment Corp ET AL Invests $3.67 Million in AbCellera Biologics Inc. $ABCL - MarketBeat

Apr 10, 2026

Apr 09, 2026

JonesTrading Initiates AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $11 - Moomoo

Apr 09, 2026

Apr 09, 2026

AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 09, 2026